<DOC>
	<DOCNO>NCT02305381</DOCNO>
	<brief_summary>This trial conduct Asia , Europe United States America ( USA ) . The aim trial investigate efficacy safety semaglutide weekly versus placebo add-on basal insulin alone basal insulin combination metformin subject type 2 diabetes .</brief_summary>
	<brief_title>Efficacy Safety Semaglutide Once-weekly Versus Placebo add-on Basal Insulin Alone Basal Insulin Combination With Metformin Subjects With Type 2 Diabetes</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus , Type 2</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Metformin</mesh_term>
	<criteria>Male female , age least 18 year time sign inform consent . For Japan : Male female , age least 20 year time signing informed consent Subjects diagnose T2DM ( type 2 diabetes mellitus ) stable diabetes treatment ( plus/minus 20 percent change total daily dose ) basal insulin ( minimum 0.25 IU/kg/day and/or 20 IU/day : insulin glargine , insulin detemir , insulin degludec and/or NPH insulin ) alone combination metformin ( minimum 1500 mg/day maximal tolerable dose ) 90 day prior screen HbA1c ( glycosylated haemoglobin ) 7.0 10.0 percent ( 53 86 mmol/mol ) inclusive Female pregnant , breastfeed intend become pregnant childbearing potential use adequate contraceptive method throughout trial include 5 week followup period ( adequate contraceptive measure require local regulation practice ) . Germany : Only highly effective method birth control accept ( ie one result less 1 % per year failure rate use consistently correctly implant , injectables , combine oral contraceptive , intrauterine device ) , sexual abstinence vasectomise partner . Japan : Adequate contraceptive measure abstinence ( sex ) , diaphragm , condom ( partner ) , intrauterine device , sponge , spermicide oral contraceptive Treatment glucose lower agent state inclusion criterion period 90 day screen . An exception shortterm treatment ( 7 day less total ) bolus insulin connection intercurrent illness Experienced 3 episode severe hypoglycaemia within 6 month prior screen , and/or hypoglycaemia unawareness History pancreatitis ( acute chronic ) Screening calcitonin value equal 50 ng/L ( pg/mL ) Personal family history medullary thyroid carcinoma ( MTC ) multiple endocrine neoplasia syndrome 2 ( MEN 2 ) Severe renal impairment define eGFR ( estimate glomerular filtration rate ) 30 mL/min/1.73 m^2 per Modification Diet Renal Disease ( MDRD ) formula ( 4 variable version ) Acute coronary cerebrovascular event within 90 day randomisation Heart failure , New York Heart Association ( NYHA ) Class IV</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2017</verification_date>
</DOC>